Concentrations of Remifentanil for Extubation

• Status: Completed
• Trial end date: 2012-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Condition of the State: (terminated, recruiting, etc.) Terminated

Study Design: Main Objective:

Compare the frequency and intensity of coughing at the time of extubation with two infusions of remifentanil that predict a plasma concentration (PC) of 3 - 4 and 2 - 3 ng/ml, through the technique of target controlled anesthesia

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seganest
• Collaborator: Instituto Para Ninos Ciegos y Sordos del Valle del Cauca
• Treatments: Remifentanil

Criteria

Inclusion Criteria:

• All patients aged 18-70 years

• Risk Scale American Society of Anaesthesiologists physical status classification (ASA) I and II

• Undergoing elective ear surgery

Exclusion Criteria:

• Patients who are contraindicated remifentanil

• Patients undergoing emergency surgery

• Pulmonary Pathology (ASTHMA - COPD)

• Index of body mass greater than 35

• Background of respiratory failure three weeks prior to the procedure

• Smokers